Accuryn Overview
- Year Founded
-
2011

- Status
-
Private
- Employees
-
42

- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$3.2M
- Investors
-
1
Accuryn General Information
Description
Developer of predictive health monitoring system designed to improve patient care using artificial intelligence and machine insights. The company's platform provides real-time measurement of intra-abdominal pressure, urine output, and core body temperature in degrees Fahrenheit and degrees Celcius, enabling medical teams to predict adverse outcomes in critical care settings better.
Contact Information
Website
www.accuryn.comCorporate Office
- 26142 Eden Landing Road
- Hayward, CA 94545
- United States
Corporate Office
- 26142 Eden Landing Road
- Hayward, CA 94545
- United States
Accuryn Timeline
Accuryn Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
13. Later Stage VC | 31-Oct-2024 | $3.2M | Completed | Generating Revenue | ||
12. Bankruptcy: Admin/Reorg | 01-Dec-2023 | Completed | Bankruptcy: Admin/Reorg | |||
11. Accelerator/Incubator | Completed | Generating Revenue | ||||
10. Later Stage VC (Series D) | 24-Mar-2023 | Completed | Generating Revenue | |||
9. Later Stage VC (Series C3) | 21-Aug-2020 | Completed | Generating Revenue | |||
8. Debt - PPP | 14-Apr-2020 | Completed | Generating Revenue | |||
7. Later Stage VC (Series C2) | 20-Dec-2019 | Completed | Generating Revenue | |||
6. Accelerator/Incubator | 01-Jun-2019 | Completed | Generating Revenue | |||
5. Later Stage VC (Series C) | 28-Feb-2019 | $29.4M | $42.5M | Completed | Generating Revenue | |
4. Later Stage VC (Series B) | 31-Aug-2018 | $8.2M | $13.1M | Completed | Startup |
Accuryn Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series D-2 | ||||||||
Series D-1 | ||||||||
Series C3 | ||||||||
Series C2 | ||||||||
Series C | ||||||||
Series B | 8,457,337 | $0.000100 | $0.03 | $1.12 | $1.12 | 1x | $1.12 | 1.51% |
Series A | 12,241,634 | $0.000100 | $0.03 | $0.49 | $0.49 | 1x | $0.49 | 2.19% |
Accuryn Comparisons
Industry
Financing
Details
Accuryn Competitors (8)
One of Accuryn’s 8 competitors is Guangdong Transtek Medical Electronics Company, a Formerly VC-backed company based in Zhongshan, China.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Guangdong Transtek Medical Electronics Company | Formerly VC-backed | Zhongshan, China | ||||
RenalSense | Venture Capital-Backed | Jerusalem, Israel | ||||
Boston Scientific | Corporation | Marlborough, MA | ||||
BD Medical Segment (Ophthalmic Systems Unit) | Formerly PE-Backed | Franklin Lakes, NJ | ||||
Google DeepMind | Venture Capital-Backed | London, United Kingdom |
Accuryn Patents
Accuryn Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20240099624-A1 | Systems, devices and methods for draining and analyzing bodily fluids, pressures and assessing health | Pending | 16-Jun-2021 | ||
AU-2022213307-A1 | Equipment adaptor assembly and equipment stand | Pending | 26-Jan-2021 | ||
AU-2022213307-A9 | Equipment adaptor assembly and equipment stand | Pending | 26-Jan-2021 | ||
CA-3204741-A1 | Equipment adaptor assembly and equipment stand | Pending | 26-Jan-2021 | ||
EP-4262674-A1 | Equipment adaptor assembly and equipment stand | Pending | 26-Jan-2021 | A61G13/102 |
Accuryn Signals
Accuryn Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Ceros Capital Markets | Venture Capital | Minority |
Accuryn Investments (1)
Accuryn’s most recent deal was a Later Stage VC with Centese for . The deal was made on 13-Mar-2020.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Centese | 13-Mar-2020 | Later Stage VC | Surgical Devices |
Accuryn FAQs
-
When was Accuryn founded?
Accuryn was founded in 2011.
-
Where is Accuryn headquartered?
Accuryn is headquartered in Hayward, CA.
-
What is the size of Accuryn?
Accuryn has 42 total employees.
-
What industry is Accuryn in?
Accuryn’s primary industry is Monitoring Equipment.
-
Is Accuryn a private or public company?
Accuryn is a Private company.
-
What is Accuryn’s current revenue?
The current revenue for Accuryn is
. -
How much funding has Accuryn raised over time?
Accuryn has raised $111M.
-
Who are Accuryn’s investors?
Ceros Capital Markets has invested in Accuryn.
-
Who are Accuryn’s competitors?
Guangdong Transtek Medical Electronics Company, RenalSense, Boston Scientific, BD Medical Segment (Ophthalmic Systems Unit), and Google DeepMind are some of the 8 competitors of Accuryn.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »